ALK-Positive Squamous Cell Carcinoma Dramatically Responded to Alectinib.
Case Rep Oncol Med
; 2018: 4172721, 2018.
Article
in En
| MEDLINE
| ID: mdl-29744229
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Case Rep Oncol Med
Year:
2018
Type:
Article
Affiliation country:
Japan